Dr Roisin Adams
National Centre for Pharmacoeconomics (NCPE), Ireland
Head of Strategy and External Engagement; Chair of the Health Technology Assessment Coordination Group
Dr. Thomas Ecker
Ecker + Ecker GmbH, Hamburg
Thomas Ecker is CEO of Ecker + Ecker. Since 2004 he has focused on HTA, Pricing and Reimbursement of pharmaceuticals. In that role he has been responsible for more than 100 G-BA submissions and price negotiations. His current focus is on EU HTA strategy and dossier development.
More information please click here.
Zealth Group, Copenhagen, Denmark
Director and Head of Nordics at Zealth and holds a Ph.D. in Economics from the University of Copenhagen. Anne Danø has 17+ years of experience in the pharmaceutical industry and consulting. Anne is an expert on market access and health economics and has a broad experience with commercialisation and launch of pharmaceuticals both globally and within the Nordic countries. At Zealth, Anne has a focus on market access, strategy development, value communication, HTA submissions and health economics targeting the Nordic countries.
Dr. Barbara Möller
Krammer, Wrbka & Partner GmbH, Wien
CEO Since 2014 Managing Director of Krammer, Wrbka & Partner Consulting GmbH - consulting for innovative pharmaceutical companies - business areas market access and reimbursement, strategic planning. 2003-2013 expertise in the areas of Market Access/Reimbursement/ External Affairs/Regulatory/Patient Advocacy in national and international innovative pharmaceutical companies Before 2013 medical doctor in Vienna Hospital Association (KAV), Vienna Health Insurance (WGKK), international NGOs
Salutem Insights Ltd., Ireland
Managing Director; Sandra Redmond is a health economist and Managing Director of Salutem Insights. She is a leading market access expert in Ireland and has 20 years experience in securing market access for new and existing medicines in Ireland.
10:00 - 15:00
You may dial in 30 minutes in advance
Dr. Henriette Wolf-Klein
Head of Department
+49 6221 500-680
This webcast combines the work of the HTA coordination group with the national preparation for the EU-HTA in the Nordic countries, Austria and Ireland.
This webcast focuses on the national preparation for the EU HTA in the Nordic countries, Austria and Ireland. Our experts will provide the latest information on national procedures during the transition period and country-specific preparations for the EU HTA. They will also provide firsthand insights into the work of the HTA coordination group.
Dr Thomas Ecker
Dr Roisin Adams
11:15 Time for discussion
11:30 Coffee break
13:15 Lunch break
Dr Thomas Ecker
Overall score of all evaluations in 2023
Five stars on Trustpilot = Excellent
Health Economics, Outcomes Research, Beobachtungsstudien, Digitalisierung - hier vertiefen Sie Ihr Know-how zur evidenzb...
In diesem Seminar erhalten Sie Know-how zur Zulassung von Arzneimitteln in Europa. Sie lernen, welche Zulassungswege mög...
Crashkurs Pharma Business Development - für Neu- und Quereinsteiger*innen
Das kompakte Basisseminar: Lernen Sie die Grundbegriffe und Essentials für Regulatory Affairs von Medizinprodukte kennen...
Der Online-Kurs gibt Ihnen einen Überblick über die Zulassung von Medizinprodukten in wichtigen Weltmärkten: Regulatoris...
Are you interested in our international continuous education programme? We provide a variety of specialised courses.Details
We team up with other companies and experts to fulfill projects worldwide.Details